Charles Explorer logo
🇨🇿

Pilot study of Flt3 Ligand comparing intraperitoneal with subcutaneous routes on hematologic and immunologic responses in patients with peritoneal carcinomatosis and mesotheliomas

Publikace na Lékařská fakulta v Hradci Králové |
2003

Tento text není v aktuálním jazyce dostupný. Zobrazuje se verze "en".Abstrakt

This study compared the clinical toxicity and hematological effects of i.p. and s.c. administration of fmslike tyroisne kinase-3-ligand, a truncated glycoprotein that increases dendritic cells and monocytes.